Chapter 1. Industry Overview of Neurovascular Devices
1.1 Definition and Scope
1.1.1 Definition of Neurovascular Devices
1.1.2 Market Segmentation
1.1.3 Years Considered for the Study
1.1.4 Assumptions and Acronyms Used
1.1.4.1 Market Assumptions and Market Forecast
1.1.4.2 Acronyms Used In Global Neurovascular Devices Market
1.2 Summary
1.2.1 Executive Summary
1.2.2 Neurovascular Devices Market By Device
1.2.3 Global Neurovascular Devices Market By Therapeutic Applications
1.2.4 Global Neurovascular Devices Market by Regions
Chapter 2. Research Approach
2.1 Methodology
2.1.1 Research Programs/By Resolution Type
2.1.2 Market Size Estimation
2.1.3 Market Breakdown and Data Triangulation
2.2 Data Source
2.2.1 Secondary Sources
2.2.2 Primary Sources
Chapter 3. Market Dynamics and Competition Analysis
3.1 Market Drivers
3.1.1 Driver 1
3.1.2 Driver 2
3.2 Restraints and Challenges
3.2.1 Restraint 1
3.2.2 Restraint 2
3.3 Growth Opportunities
3.3.1 Opportunity 1
3.3.2 Opportunity 2
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitute
3.4.4 Threat of New Entrants
3.4.5 Degree of Competition
3.5 Value Chain Analysis
3.6 Cost Structure Analysis
3.6.1 Proportion of Manufacturing Cost Structure
3.6.1.1 Raw Material
3.6.1.2 Labor Cost
3.6.1.3 Manufacturing Expense
3.7 Regulatory Compliance
3.8 Competitive Landscape, 2019
3.8.1 Player Positioning Analysis
3.8.2 Key Strategies Adopted By Leading Players
Chapter 4. Neurovascular Devices Market By Device
4.1 Introduction
4.2 Global Neurovascular Devices Revenue (US$ Mn) by Device
4.2.1 Global Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 – 2027
4.2.2 Cerebral Embolization and Aneurysm Coiling Devices
4.2.2.1 Cerebral Embolization and Aneurysm Coiling Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.2.3 Cerebral Angioplasty and Stenting Systems
4.2.3.1 Cerebral Angioplasty and Stenting Systems Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.2.4 Neurothrombectomy Devices
4.2.4.1 Neurothrombectomy Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.2.5 Support Devices
4.2.5.1 Support Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.3 Market Attractive Analysis By Device 2019
Chapter 5. Neurovascular Devices Market By Therapeutic Applications
5.1 Introduction
5.2 Global Neurovascular Devices Revenue (US$ Mn) by Therapeutic Applications
5.2.1 Global Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 – 2027
5.2.2 Stroke
5.2.2.1 Stroke Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.3 Cerebral Artery
5.2.3.1 Cerebral Artery Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.4 Cerebral Aneurysm
5.2.4.1 Cerebral Aneurysm Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.5 Others
5.2.5.1 Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.3 Market Attractive Analysis By Therapeutic Applications 2019
Chapter 6. North America Neurovascular Devices Market By Country
6.1 North America Neurovascular Devices Market Overview
6.2 U.S.
6.2.1 U.S. Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
6.2.2 U.S. Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
6.3 Canada
6.3.1 Canada Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
6.3.2 Canada Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
6.4 North America PEST Analysis
Chapter 7. Europe Neurovascular Devices Market By Country
7.1 Europe Neurovascular Devices Market Key Overview
7.2 UK
7.2.1 UK Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
7.2.2 UK Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
7.3 Germany
7.3.1 Germany Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
7.3.2 Germany Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
7.4 France
7.4.1 France Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
7.4.2 France Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
7.5 Spain
7.5.1 Spain Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
7.5.2 Spain Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
7.6 Rest of Europe
7.6.1 Rest of Europe Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
7.6.2 Rest of Europe Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
7.7 Europe PEST Analysis
Chapter 8. Asia-Pacific Neurovascular Devices Market By Country
8.1 Asia Pacific Neurovascular Devices Market Overview
8.2 China
8.2.1 China Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
8.2.2 China Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
8.3 Japan
8.3.1 Japan Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
8.3.2 Japan Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
8.4 India
8.4.1 India Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
8.4.2 India Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
8.5 Australia
8.5.1 Australia Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
8.5.2 Australia Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
8.6 South Korea
8.6.1 South Korea Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
8.6.2 South Korea Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
8.7 Rest of Asia-Pacific
8.7.1 Rest of Asia Pacific Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
8.7.2 Rest of Asia Pacific Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
8.8 Asia Pacific PEST Analysis
Chapter 9. Latin America Neurovascular Devices Market By Country
9.1 Latin America Neurovascular Devices Market Overview
9.2 Brazil
9.2.1 Brazil Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
9.2.2 Brazil Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
9.3 Mexico
9.3.1 Mexico Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
9.3.2 Mexico Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
9.4 Rest of Latin America
9.4.1 Rest of Latin America Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
9.4.2 Rest of Latin America Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
9.5 Latin America PEST Analysis
Chapter 10. Middle East & Africa Neurovascular Devices Market By Country
10.1 Middle East & Africa Neurovascular Devices Market Overview
10.2 Saudi Arabia
10.2.1 Saudi Arabia Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
10.2.2 Saudi Arabia Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
10.3 UAE
10.3.1 UAE Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
10.3.2 UAE Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
10.4 Rest of Middle East & Africa
10.4.1 Rest of Middle East & Africa Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Device, 2016 - 2027
10.4.2 Rest of Middle East & Africa Neurovascular Devices Market Revenue (US$ Mn) and Forecast By Therapeutic Applications, 2016 - 2027
10.5 Middle East & Africa PEST Analysis
Chapter 11. Player Analysis of Neurovascular Devices
11.1 Global Neurovascular Devices Market Company Share Analysis
11.2 Competition Matrix
11.2.1 Mergers And Acquisition In Global Neurovascular Devices Market
Chapter 12. Company Profile
12.1 Medtronic
12.1.1 Company Snapshot
12.1.2 Business Overview
12.1.3 Financial Overview
12.1.3.1 Revenue (US$ Mn), 2019
12.1.3.2 Medtronic 2019 Neurovascular Devices Business Regional Distribution
12.1.4 Product/Service and Specifications
12.1.5 Manufacturing Plant Footprint Analysis
12.2 Stryker Corporation
12.3 Johnson & Johnson
12.4 Terumo Corporation
12.5 Penumbra, Inc.
12.6 Boston Scientific Corporation
12.7 Microport Scientific Corporation
12.8 W.L. Gore & Associates, Inc.
12.9 Abbott Laboratories
12.10 Others
Growing prevalence of chronic neurological disorder across the globe, rapid technological advancements in medical devices and increasing demand for minimally invasive surgical devices are major factors expected to drive the growth of global market.
The global neurovascular devices market in 2027 is expected to be above US$ 4.2 Bn.
In product segment the MABs segment is growing at faster pace.
The CAGR of the global neurovascular devices market from 2020-2027 is above 5.8%.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are Penumbra, Inc., Boston Scientific Corporation, Microport Scientific Corporation.
The Asia Pacific is expected to account for major revenue share in the global market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date